Journal
/
/
Paramyxovirus for Tumor-målrettet Immunomodulation: Design og evaluering Ex Vivo
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
DOI:

12:42 min

January 07, 2019

,

Chapters

  • 00:04Title
  • 00:47Generation of Recombinant Virus Particles
  • 02:47Collection and Propagation of Virus Particles
  • 05:11Viral Titer Evaluation
  • 06:59Determining Replicative and Cytotoxic Capacities of Viral Vectors Encoding Immunomodulators
  • 08:03Assessment of Immunological Functionality of Isolated Virus-encoded Immunomodulators from Infected Cells
  • 10:00Results: Evaluation of Tumor-targeted Immunomodulation by Paramyxoviruses
  • 11:37Conclusion

Summary

Automatic Translation

Denne protokol beskriver en detaljeret arbejdsgang for generation og ex vivo karakterisering af oncolytic virus for udtryk for hæmmende, ved hjælp af mæslinger virus kodning bispecific T-celle ager som eksempel. Ansøgning og tilpasning til andre vektor platforme og transgener vil fremskynde udviklingen af nye immunovirotherapeutics for klinisk oversættelse.

Related Videos

Read Article